StonvexLoading…
StonvexStonvexStonvexCore line items from MDWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.96M | $20.22M | $18.69M | $26.50M |
Operating Income | $-25.27M | $-19.40M | $-15.29M | $-8.35M |
Net Income | $-23.88M | $-30.22M | $-6.72M | $-19.60M |
EPS (Diluted) | $-2.10 | $-3.03 | $-0.75 | $-3.93 |
Total Assets | $86.25M | $73.50M | $66.46M | $50.02M |
Total Liabilities | $42.62M | $42.34M | $34.86M | $39.10M |
Cash & Equivalents | $4.80M | $9.15M | $11.87M | $33.90M |
Free Cash Flow OCF − CapEx | $-21.63M | $-19.90M | $-16.93M | $-12.44M |
Shares Outstanding | 12.84M | 10.79M | 9.22M | 7.24M |